# Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients

> **NCT01641913** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **OTHER:** Absorbable sugars

## Key facts

- **NCT ID:** NCT01641913
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01641913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01641913, "Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01641913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*